Chronicle Journal: Finance

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY: BMY )

57.04 USD -1.32 (-2.26%)
Streaming Delayed Price Updated: 1:55 PM EDT, Oct 18, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,724,776
Open 58.01
Bid (Size) 57.03 (19)
Ask (Size) 57.04 (4)
Prev. Close 58.36
Today's Range 57.02 - 58.15
52wk Range 56.66 - 69.75
Shares Outstanding 2,222,113,553
Dividend Yield 3.44%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Celebrating the Science That Transforms Patients' Lives
Tags Samit Hirawat Innovation & Technology Research, Reports & Publications
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Team BMS Moves for Minutes to Benefit Special Olympics
Tags Health & Healthcare Team BMS NYSE: BMY
From 3BL Media: Corporate Social Responsibility, Energy and Health News

Performance

YTD
-7.07%
-7.07%
1 Month
-6.96%
-6.96%
3 Month
-14.04%
-14.04%
6 Month
-13.05%
-13.05%
1 Year
-6.14%
-6.14%

More News

Read More
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia (ozanimod) as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis
From Business Wire News Releases
OLA and PRIDE Alliance PBRGs teamed up to host an empowering storytelling forum
Tags Responsible Business & Employee Engagement Pride NYSE: BMY
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Bristol Myers Squibb Announces Up to Five Years of Data from Long-Term DAYBREAK Study Reinforcing Efficacy and Safety Profile of Zeposia (ozanimod) in Patients with Relapsing Forms of Multiple Scleros
From Business Wire News Releases
2 Best Biotech Stocks to Buy Right Now
Tags AMGN MRK ABBV
From Motley Fool
2 Top Biotech Stocks to Buy in October
Tags PFE JNJ BMY
From Motley Fool
Week in Review: Hansoh Signs $456 Million Deal for siRNA Products
From ChinaBio® Today
Week in Review: Hansoh Signs $456 Million Deal for siRNA Products
From ChinaBio® Today
Week In Review: Hansoh Signs $456 Million Deal For siRNA Products
Tags Stocks / Equities Market News Pharma/Biotech
From TalkMarkets
This Company Revolutionizes What Matters for Hospitals, Big Pharma and Health Insurers
Tags Healthcare Triangle Partner Content BMY
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

© Copyright 2015, Chronicle Journal, Thunder Bay, ON. Powered by BLOX Content Management System from TownNews.com. [Terms of Use | Privacy Policy]